Angitia Biopharmaceuticals (Series C)
Funding Details
- Date Award
- May 30, 2025
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $120,000,000
Company Info
- Founding Year
- 2016
- Company Description
- Angitia Biopharmaceuticals is developing treatments for serious musculoskeletal diseases like osteoporosis.
- Market
- Musculoskeletal diseases
- Location
- Woodland Hills, California, USA
- Coinvestors
- Bain Capital Life Sciences, Janus Henderson, OrbiMed, 3H Health Investment, Yonghua Capital, Legend Capital, Elikon Venture